Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Poirier

Showing results (101-110 of 248) with videos related to

Pageof 25
Sort By:
Genes & Development|November 1, 1993
Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) geneL Jeannotte, M Lemieux, J Charron, et al.
Australian Dental Journal|February 22, 2023
Advertising and general dental practice: how compliant are practice websites in Australia with legal requirements?E D Jensen, S Sethi, B F Poirier, et al.
SAR and QSAR in Environmental Research|October 3, 1999
Multivariate analysis of metal concentration profiles in mushroomsE Siobud-Dorocant, J C Doré, D Michelot, et al.
Developmental Biology|October 10, 1996
Role of galectin-1 in the developing mouse olfactory systemA C Puche, F Poirier, M Hair, et al.
Psychopharmacology|January 1, 1985
Changes in human platelet 5 HT level after 1 week of chlorimipramine treatmentM F Poirier, K H Le Quan-Bui, H Lôo, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Premedication: a comparison of pethidine-promethazine/hydroxyzine/midazolam]C Leomy, B Greffe, M C Boudel, et al.
L'Encephale|January 1, 1993
[Mortality and cause of death in schizophrenia. Review of the literature]K Tabbane, R Joober, C Spadone, et al.
L'Encephale|February 11, 2000
[First clinical episode of bipolar disorders: a study within a population of bipolar I and bipolar II French patients]O Canceil, R Bouzid, J P Olíe, et al.
Neuropsychobiology|January 1, 1985
Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycleM F Poirier, H Lôo, T Dennis, et al.
L'Encephale|December 17, 2009
[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study]J-P Olié, D Gourion, A Montagne, et al.
Pageof 25

Showing results (101-110 of 248) with videos related to

Sort By:
Pageof 25
Genes & Development|November 1, 1993
Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) geneL Jeannotte, M Lemieux, J Charron, et al.
Australian Dental Journal|February 22, 2023
Advertising and general dental practice: how compliant are practice websites in Australia with legal requirements?E D Jensen, S Sethi, B F Poirier, et al.
SAR and QSAR in Environmental Research|October 3, 1999
Multivariate analysis of metal concentration profiles in mushroomsE Siobud-Dorocant, J C Doré, D Michelot, et al.
Developmental Biology|October 10, 1996
Role of galectin-1 in the developing mouse olfactory systemA C Puche, F Poirier, M Hair, et al.
Psychopharmacology|January 1, 1985
Changes in human platelet 5 HT level after 1 week of chlorimipramine treatmentM F Poirier, K H Le Quan-Bui, H Lôo, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Premedication: a comparison of pethidine-promethazine/hydroxyzine/midazolam]C Leomy, B Greffe, M C Boudel, et al.
L'Encephale|January 1, 1993
[Mortality and cause of death in schizophrenia. Review of the literature]K Tabbane, R Joober, C Spadone, et al.
L'Encephale|February 11, 2000
[First clinical episode of bipolar disorders: a study within a population of bipolar I and bipolar II French patients]O Canceil, R Bouzid, J P Olíe, et al.
Neuropsychobiology|January 1, 1985
Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycleM F Poirier, H Lôo, T Dennis, et al.
L'Encephale|December 17, 2009
[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study]J-P Olié, D Gourion, A Montagne, et al.
Pageof 25